Back
  1. Endocrinology

Endocrinology

Timely detection and diagnosis of hormone-related diseases can significantly improve prognosis. With our extensive data repository of rare diseases, we can provide you with a comprehensive medical report, including recommendations and a differential diagnosis, if applicable – allowing for genetic counseling and treatment decisions.

Diabetes and obesity panel

Our diabetes and obesity panel is recommended for patients with abnormalities in glucose metabolism, such as hyperinsulinemic hypoglicemia, diabetes neonatal, MODY, diabetes in adults, and familial hypercholesterolemia as well as for patients displaying insulin resistance, from mild to the severe spectrum (Donohue syndrome), and for patients with familial hyperinsulinism. Disorders caused by imprinting errors or uniparental disomy such as 6q24-related transient neonatal diabetes mellitus and Beckwith Wiedemann syndrome are not detected wtih this panel.

No. of genes:155
TAT:25 days
Coverage:≥99.5% ≥20x
Details:MLPA: 15q11

COMMON SYNDROMES AND DISORDERS COVERED

Bardet-Biedl syndrome
Congenital hyperinsulinism
Diabetes neonatal
Familial hypercholesterolemia
Hypoglycemia
Maturity onset diabetes of the young
Neonatal diabetes
Obesity

Pancreatitis panel

Our pancreatitis panel includes genes associated with chronic pancreatitis and for differential diagnosis, it includes genes associated with pancreatic cancer.

No. of genes:29
TAT:25 days
Coverage:≥99.5% ≥20x

COMMON SYNDROMES AND DISORDERS COVERED

Pancreatic cancer
Pancreatitis

Congenital adrenal hyperplasia panel

Our congenital adrenal hyperplasia (CAH) panel is designed for patients suspected of having CAH. CAH is a group of inherited disorders characterized by improper functioning of the adrenal glands, leading to abnormal production of steroid hormones, such as a cortisol or aldosterone. Our panel includes the analysis of the CYP21A2 gene, which codes for the enzyme 21-hydroxylase. More than 90% of CAH cases are caused by a deficiency of this enzyme.

No. of genes:8
TAT:25 days
Coverage:≥99.5% ≥20x
Details:CYPA21A2 analysis

COMMON SYNDROMES AND DISORDERS COVERED

Congenital adrenal hyperplasia

Get in touch with our Partner Support

Our consultation service is available in several languages.

+49 (0) 381 - 80113 416

Mon. – Fri. 7 a.m.– 8 p.m. CET • Sat. 9 a.m. – 5 p.m. CET

For our US Partners:

+1 (617) 580-2102

Mon. – Fri. 9 a.m. – 5:30 p.m. EST